Dr. Kevin Kenneth Veverka, MD

Dr. Veverka practices at Blount Memorial Physician Group, Inc. in Maryville, Tennessee.

Dr. Veverka's NPI, 1831694827, was assigned on March 29, 2018. Dr. Veverka graduated from Mayo Medical School in 2018. Dr. Veverka holds Tennessee license 64806.

Dr. Veverka's primary practice is Blount Memorial Physician Group, Inc., at 103 W Broadway Ave, Maryville, TN 37801 in Blount County. The practice phone is (865) 984-3864.

Dr. Veverka's primary practice is Blount Memorial Physician Group, Inc. in Maryville, Tennessee. Dr. Veverka is also affiliated with Prisma Health Blount Memorial Hospital. The medical group on file is Blount Memorial Physicians Group. Dmand AI also links Dr. Veverka to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Veverka practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Veverka's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Veverka is licensed in Tennessee.

CMS data shows 2,248 Medicare services from Dr. Veverka across 18 procedure codes in 2024, for 594 Medicare patients. Medicare paid $97,802 for them. Every service was in an office.

CMS counts 594 Medicare patients who saw Dr. Veverka in 2024. The largest group is 65 to 74, with 285 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.02, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Veverka's median patient age at 66, with 51% women.

In 2024, Dr. Veverka wrote 1,327 Medicare Part D claims for 528 patients. 96% of them were for generic drugs. CMS names the drug for 1,177 of them, across 17 drugs with 11 or more claims each, at $119,170 in total drug cost. In 2023, CMS named 858 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 78 out of 100 for Dr. Veverka for performance year 2024, reported as part of a group. Dr. Veverka accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 585 procedures of removal of skin lesions by Dr. Veverka, more than 88% of the clinicians it reports for that procedure.

Dmand AI links 12 papers to Dr. Veverka, published from 2017 to 2023. 2017 was the busiest year, with 4. The most frequent topics are Tomography, Optical Coherence, Dermatitis, Allergic Contact and Patch Tests. Dr. Veverka has published most often in Dermatitis. Dr. Veverka's most frequent co-authors are Lisa A. Drage, MD, Erik J. Stratman, MD and Christian Lee Baum, MD.

CMS Open Payments shows 378 general payments to Dr. Veverka from 24 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 96% of the total. Novartis Pharmaceuticals Corporation paid the most, $1,050.

Dr. Veverka graduated from Mayo Medical School in 2018.